Literature DB >> 22560511

Developmental origins of brain tumors.

Chong Liu1, Hui Zong.   

Abstract

Brain tumors are devastating owing to the high fatality rate and the devastating impact on life qualities of patients. Recent advancement of comparative transcriptome profiling tools and mouse genetic models has greatly deepened our understanding of the developmental origins of these tumors, which could lead to effective therapeutic strategies. We review recent progresses in three types of brain tumors: ependymoma, medulloblastoma, and malignant glioma. The conceptual framework established by these studies converged on three important aspects. First, subtypes in each tumor group originate from distinct cell types. Second, each cell-of-origin is uniquely susceptible to some but not other genetic mutations. Lastly, mutant stem cells may not transform until they differentiate into more restricted progenitor cell type. Overall, these findings indicate the existence of intricate interactions between gene mutations and developmental program for the formation of brain tumors.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22560511      PMCID: PMC3432164          DOI: 10.1016/j.conb.2012.04.012

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  37 in total

1.  Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

Authors:  Piergiorgio Modena; Elena Lualdi; Federica Facchinetti; Joris Veltman; James F Reid; Simone Minardi; Irene Janssen; Felice Giangaspero; Marco Forni; Gaetano Finocchiaro; Lorenzo Genitori; Flavio Giordano; Riccardo Riccardi; Eric F P M Schoenmakers; Maura Massimino; Gabriella Sozzi
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

2.  Mosaic analysis with double markers in mice.

Authors:  Hui Zong; J Sebastian Espinosa; Helen Hong Su; Mandar D Muzumdar; Liqun Luo
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

Review 3.  Mammalian neural stem cells.

Authors:  F H Gage
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

4.  Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.

Authors:  Yuan Zhu; Frantz Guignard; Dawen Zhao; Li Liu; Dennis K Burns; Ralph P Mason; Albee Messing; Luis F Parada
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

5.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

6.  Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Authors:  Keith L Ligon; Emmanuelle Huillard; Shwetal Mehta; Santosh Kesari; Hongye Liu; John A Alberta; Robert M Bachoo; Michael Kane; David N Louis; Ronald A Depinho; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

7.  Radial glia cells are candidate stem cells of ependymoma.

Authors:  Michael D Taylor; Helen Poppleton; Christine Fuller; Xiaoping Su; Yongxing Liu; Patricia Jensen; Susan Magdaleno; James Dalton; Christopher Calabrese; Julian Board; Tobey Macdonald; Jim Rutka; Abhijit Guha; Amar Gajjar; Tom Curran; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

8.  Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.

Authors:  Mukesh K Sharma; David B Mansur; Guido Reifenberger; Arie Perry; Jeffrey R Leonard; Kenneth D Aldape; Meredith G Albin; Ryan J Emnett; Simon Loeser; Mark A Watson; Rakesh Nagarajan; David H Gutmann
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

9.  Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM).

Authors:  Mandar Deepak Muzumdar; Liqun Luo; Hui Zong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

10.  Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

Authors:  Robert M Bachoo; Elizabeth A Maher; Keith L Ligon; Norman E Sharpless; Suzanne S Chan; Mingjian James You; Yi Tang; Jessica DeFrances; Elizabeth Stover; Ralph Weissleder; David H Rowitch; David N Louis; Ronald A DePinho
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

View more
  17 in total

1.  Wnt signaling and astrocytic brain tumors.

Authors:  Nives Pećina-Šlaus; Anja Kafka
Journal:  CNS Oncol       Date:  2015

2.  Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells.

Authors:  Peng Zhang; Ying Lu; Xue You Liu; Yu Hua Zhou
Journal:  Tumour Biol       Date:  2014-09-30

Review 3.  Cell of origin for malignant gliomas and its implication in therapeutic development.

Authors:  Hui Zong; Luis F Parada; Suzanne J Baker
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

Review 4.  It takes two to tango, a dance between the cells of origin and cancer stem cells in the Drosophila larval brain.

Authors:  Derek H Janssens; Cheng-Yu Lee
Journal:  Semin Cell Dev Biol       Date:  2014-03-11       Impact factor: 7.727

5.  L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration.

Authors:  Shenghong Ma; Renqiang Sun; Bowen Jiang; Jun Gao; Wanglong Deng; Peng Liu; Ruoyu He; Jing Cui; Minbiao Ji; Wei Yi; Pengyuan Yang; Xiaohui Wu; Yue Xiong; Zilong Qiu; Dan Ye; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2017-03-31       Impact factor: 4.272

6.  ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.

Authors:  Kate Marie Lewis; Claudia Petritsch
Journal:  Transl Neurosci       Date:  2013-12       Impact factor: 1.757

Review 7.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

8.  Luminal cells are favored as the cell of origin for prostate cancer.

Authors:  Zhu A Wang; Roxanne Toivanen; Sarah K Bergren; Pierre Chambon; Michael M Shen
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

9.  The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.

Authors:  Alex L Tobias; Bart Thaci; Brenda Auffinger; Esther Rincón; Irina V Balyasnikova; Chung Kwon Kim; Yu Han; Lingjiao Zhang; Karen S Aboody; Atique U Ahmed; Maciej S Lesniak
Journal:  Stem Cells Transl Med       Date:  2013-08-07       Impact factor: 6.940

Review 10.  Deregulated proliferation and differentiation in brain tumors.

Authors:  Fredrik J Swartling; Matko Čančer; Aaron Frantz; Holger Weishaupt; Anders I Persson
Journal:  Cell Tissue Res       Date:  2014-11-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.